- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Joe Mclane, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers.
Joe McLane
Senior Manager, Global Marketing Communications, HPV Franchise, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers. I wanted to have a career in pharma, and. more importantly, at Merck, because I wanted to be part of something bigger and make a difference. My major accomplishments so far include "Tell Someone," a disease campaign that educated women on the link between cervical cancer and human papillomavirus, and the launch of "One Less," our branded campaign that announced the availability of [HPV vaccine] Gardasil.
Social networks are the new frontier for pharma. Social networks, word-of-mouth initiatives, and other social media will help stimulate conversations. Consumers trust healthcare information they learn in social circles; we are now exploring how to work with these unique networks to further our messages.
In 10 years, I hope to be doing what I love to do with people who are as passionate as I am. I'm trying to convince myself that 40 is the new 30.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
